Association Briefs

The Merger That Didn’t Happen After months of discussions, plans for a merger of the nation’s two largest biotechnology associations have fallen through. The Industrial Biotechnology Association had proposed joining forces with the Association of Biotechnology Companies in July. In discussions that went on through the summer, the two Washington-based organizations couldn’t resolve questions about equal representation of their members, according to the ABC’s new executiv

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

After months of discussions, plans for a merger of the nation’s two largest biotechnology associations have fallen through. The Industrial Biotechnology Association had proposed joining forces with the Association of Biotechnology Companies in July. In discussions that went on through the summer, the two Washington-based organizations couldn’t resolve questions about equal representation of their members, according to the ABC’s new executive director, Pamela Bridgen. Although there is some overlapping between the two groups, IBA’s member companies tend to be larger and pay higher dues than those in the ABC, which also includes noncorporate groups like universities and independent institutes. The ABC has now proposed a “Biotechnology Association’s Roundtable,” which would meet quarterly to review biotechnology issues and plan strategy, but Richard Godown, the IBA president, says the idea “seems improbable at this time" and suggested that the ABC’s rejection of the merger will likely mean less collaboration. Although both groups ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA